HuMax-HepC

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHuMax-HepC
Drug Alias NameHCV-specific antibody (Genmab)E2-hmAbhepatitis C virus-specific antibody (Connex/INSERM)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionHepatitis C virus E2 glycoprotein inhibitors
TargetsHepatitis C virus E2 glycoprotein
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenmab A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConnext Co LtdInsermGenmab A/S
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A